BCL2 and cholangiocarcinoma: We examined expression levels of genes associated with the AKT signaling such as mTOR and the BCL2 superfamily in cholangiocarcinoma organoids under glucose-free condition after treatment with LY294002, but there was no significant difference in the expression levels of these genes by inhibition of AKT phosphorylation (Supplementary Figure S2).